Antisense oligonucleotides (ASOs) represent a new and highly promising class of drugs for
personalized medicine. In the last decade, major chemical developments and improvements …

Most genetic alterations that drive melanoma development and resistance to targeted therapy
have been uncovered. In contrast, and despite their increasingly recognized contribution, …

Antisense oligonucleotides (ASOs) are an increasingly represented class of drugs. These
small sequences of nucleotides are designed to precisely target other oligonucleotides, …

The COVID‐19 crisis and the development of the first approved mRNA vaccine have highlighted
the power of RNA‐based therapeutic strategies for the development of new medicines. …

Uveal melanoma (UM), the most common primary intraocular tumor in adults, has been
extensively characterized by omics technologies during the last 5 yr. Despite the discovery of …

Most genetic alterations that drive melanoma development and resistance to targeted therapy
have been uncovered. In contrast, and despite their increasingly recognized contribution, …

Uveal melanoma (UM), the most common primary intraocular tumor in adults, has been
extensively characterized by omics technologies during the last 5 years. Despite the discovery of …

Programme 1re journée de colloque jeudi 6 avril 2023 8h30 9h00 Accueil des participants
OUVERTURE DU COLLOQUE (Allocutions et mots d’accueil) Mot d’introduction Nicolas …

We assess the feasibility of using diffuse reflectance spectroscopy (DRS) and coherent anti-Stokes
Raman scattering spectroscopy (CARS) as optical tools for human brain tissue …

Deep brain stimulation (DBS) surgery is performed on patients suffering Parkinson’s disease
for whom medication is no longer effective in relieving their symptoms. The outcomes of the …